Fanconi Anemia Complementation Group U C4310651
A rare genetic disorder impairing DNA repair. It primarily affects children and increases risk of bone marrow failure and cancer. Treatment includes supportive care and possibly stem cell transplant.
Key facts at a glance
- ICD-10
- D61.03
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Bone marrow failure
(hematologic)Generalized symptoms
(hematologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Fatigue
(hematologic)Renal anomalies
(hematologic)Congenital heart defect
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Hematopoietic Stem Cell Transplantation
Primary curative modality for end-stage bone marrow failure through myeloablative conditioning and stem cell rescue. Success rates depend on donor match quality and patient age.
Medication management with follow-up
Active treatment with regular monitoring by a healthcare provider is recommended.
Blood Product Transfusion Support
Red blood cell and platelet transfusions maintain adequate hemoglobin and prevent bleeding complications in transfusion-dependent patients. Leukocyte-reduced products reduce alloimmunization risk.
Additional treatment options
Prophylactic Antimicrobial Therapy
Antibacterial and antifungal prophylaxis during neutropenic phases to prevent opportunistic infections. Selection based on local resistance patterns and patient allergy history.
medicationExercise and Rehabilitation Program
Tailored physical activity program maintaining muscle strength and functional capacity during treatment. Helps counteract deconditioning from anemia and prolonged treatment periods.
physical_therapySolid Tumor Surveillance Protocol
Annual imaging studies and targeted screening for head and neck, esophageal, and anogenital malignancies. Early detection through structured surveillance improves treatment outcomes.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Fanconi Anemia Complementation Group U C4310651?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Fanconi Anemia Complementation Group U C4310651. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy